Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Kadmon Holdings Inc. (KDMN)

2.64   0.07 (2.72%) 08-20 14:17
Open: 2.56 Pre. Close: 2.57
High: 2.71 Low: 2.55
Volume: 681,815 Market Cap: 342M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.612 - 2.622 2.622 - 2.634
Low: 2.295 - 2.305 2.305 - 2.316
Close: 2.55 - 2.567 2.567 - 2.587

Technical analysis

as of: 2019-08-20 1:59:51 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.22     One year: 3.77
Support: Support1: 2.43    Support2: 2.22
Resistance: Resistance1: 2.76    Resistance2: 3.22
Pivot: 2.47
Moving Average: MA(5): 2.53     MA(20): 2.49
MA(100): 2.31     MA(250): 2.56
MACD: MACD(12,26): 0.06     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 68.28     %D(3): 55.47
RSI: RSI(14): 61.07
52-week: High: 4.39  Low: 1.63  Change(%): -22.2
Average Vol(K): 3-Month: 93111  10-Days: 44775

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
KDMN has closed below upper band by 0.0%. Bollinger Bands are 20.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 14 Aug 2019 15:18:32 Z
Kadmon (KDMN) Completes Enrollment in KD025 Study for cGVHD

Thu, 01 Aug 2019 17:03:30 Z
Will Kadmon Holdings (KDMN) Report Negative Q2 Earnings? What You Should Know

Thu, 11 Jul 2019 17:12:22 Z
Moleculin Files New Patents for Cancer Candidate Annamycin

Thu, 11 Jul 2019 00:07:34 Z
Kadmon Initiates Dosing in Study for Systemic Sclerosis Drug

Wed, 08 May 2019 21:03:51 Z
After Hours Most Active for May 8, 2019 : DWDP, NLY, KDMN, PFE, DIS, TSM

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 126.91
Shares Float (M) 82.41
% Held by Insiders 0.43
% Held by Institutions 66.15
Shares Short (K) 7100
Shares Short P. Month (K)

Stock Financials

EPS -0.372
EPS Est. Current Year -1.550
EPS Est. Next Year -1.750
EPS Est. Next Quarter -0.370
Forward EPS -0.961
Book Value (p.s.) 0.770
PEG Ratio
Profit Margin
Operating Margin -13410.26
Return on Assets (ttm) -30.0
Return on Equity (ttm) -30.4
Qtrly Rev. Growth -86.4
Gross Profit (p.s.) 0.006
Sales Per Share
EBITDA (p.s.) -0.751
Qtrly Earnings Growth -57.40
Operating Cash Flow (M) -79.80
Levered Free Cash Flow (M) -44.42

Stock Valuations

P/E -7.19
P/E Growth Ratio 0.04
P/BV 3.47
P/S 33957308416.00
P/CF -4.26

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.